The Precursor Problem in PFAS Risk Assessment
PFAS risk assessment has historically focused on perfluoroalkyl acids (PFAAs) — the terminal transformation products that accumulate in blood, tissues, and the environment. But a large and structurally diverse class of PFAS compounds, collectively termed precursors, can be metabolized in the human body into PFAAs following ingestion. These precursor compounds include fluorotelomer alcohols (FTOHs), perfluoroalkyl sulfonamides (FASAs), and their derivatives, many of which are present in drinking water and on food packaging but are not detected by standard PFAA-targeted analytical methods.
The gap between measured PFAA exposure and actual PFAS body burden attributable to precursor bioactivation is substantial. Studies using suspect screening and total oxidizable precursor (TOP) assays on drinking water samples have found that the precursor-derived PFAA load can exceed the directly measured PFAA concentration by a factor of two to five in some water sources. This means that exposure assessments relying solely on direct PFAA measurement — including those used to determine compliance with current MCLs — may significantly underestimate the health-relevant PFAS dose that residents are actually receiving.
Metabolic Pathways: FTOHs to PFCAs
Fluorotelomer alcohols are among the most thoroughly studied PFAS precursors. 8:2 FTOH, for example, undergoes hepatic oxidation through a series of intermediate compounds before yielding PFOA and PFNA as terminal products. This biotransformation has been demonstrated in vitro using human liver microsomes and in vivo in multiple mammalian species, with conversion efficiencies that depend on dose, exposure duration, and co-exposure to other cytochrome P450 substrates. Animal studies have shown that chronic oral administration of 8:2 FTOH produces serum PFOA concentrations that closely mirror those seen after equivalent PFOA dosing, confirming the biological relevance of precursor conversion.
Shorter-chain FTOHs (4:2, 6:2) follow analogous metabolic pathways, generating PFBA and PFHxA as primary products. While these short-chain carboxylates are excreted more rapidly than PFOA, the continuous replenishment of precursor exposure from food contact materials and contaminated water ensures that metabolically generated short-chain PFCAs contribute to an ongoing internal body burden. The regulatory challenge is that precursor FTOH concentrations in drinking water are not currently measured under any national MCL framework.
FASAs and Sulfonamide Precursors
N-methyl perfluorooctane sulfonamide (N-MeFOSA) and related fluoroalkyl sulfonamide precursors represent a second major class of PFAS precursors. These compounds, used historically in Scotchgard fabric protectors and other consumer products, undergo stepwise metabolic demethylation and oxidation to yield PFOS and related sulfonates. Biomonitoring studies in populations with historical FASA exposure have documented serum PFOS concentrations that cannot be fully explained by direct PFOS intake, implicating sulfonamide precursor metabolism as a contributing exposure pathway.
The clinical significance of precursor-derived PFOS exposure is amplified by PFOS’s long human half-life (~5 years) and its established associations with immune suppression, thyroid disruption, and developmental toxicity. Individuals consuming water or food containing sulfonamide precursors may be accumulating PFOS-equivalent body burden without any PFOS appearing in standard water quality analyses — a scenario with direct implications for both clinical interpretation of serum PFAS measurements and regulatory compliance determinations.
Implications for Filter Adequacy and Exposure Assessment
Most activated carbon and reverse osmosis filtration systems are optimized for removal of ionic PFAAs — the same compounds targeted by current MCLs. Precursor PFAS compounds, particularly neutral FTOHs, have very different physicochemical properties: lower charge, higher volatility, and different adsorption kinetics. Studies have found that granular activated carbon (GAC) filters designed for PFAA removal achieve substantially lower removal efficiencies for fluorotelomer alcohols under realistic contact time and loading conditions.
This creates a regulatory and public health blind spot. A household or utility using a certified, high-performance PFAA filter may remove 99% of measured PFCAs and PFSAs while passing through precursor compounds that will be metabolized to PFAAs after ingestion. The body burden consequence of this precursor pass-through has not been quantified for typical U.S. or European drinking water sources, but the chemistry is unambiguous: precursor conversion occurs, and the resulting PFAAs are toxicologically identical to those that would have been removed by a more precursor-inclusive treatment approach. Exposure assessment frameworks that ignore precursors systematically underestimate the PFAS body burden resulting from drinking water consumption.